ArticleiScience2022

Anti-viral efficacy of a next-generation CD4-binding site bNAb in SHIV-infected animals in the absence of anti-drug antibody responses.

Sarah E Lovelace et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.